ABOUT THIS EVENT

Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company dedicated to utilizing its proprietary gene engineering platform technologies to create next generation cell and gene therapeutics, rings the Nasdaq Opening Bell remotely from across the country.

Eric Ostertag, M.D., Ph.D., CEO of Poseida, rings the Opening Bell alongside the Company’s team in a virtual bell ringing ceremony.